Rheumatic fever is an inflammatory disease that can develop as a complication of untreated or poorly treated streptococcal throat infections, particularly those caused by group A Streptococcus. It primarily affects children and adolescents, although adults can also be affected. One of the key aspects of rheumatic fever is its basis in hypersensitivity reactions, which involve the immune system responding abnormally to the bacterial antigens. Understanding the type of hypersensitivity involved is essential for comprehending the disease’s pathology, clinical manifestations, and treatment strategies.
Pathophysiology of Rheumatic Fever
The pathogenesis of rheumatic fever involves an autoimmune reaction triggered by molecular mimicry between streptococcal antigens and human tissues. The immune system produces antibodies against the group A Streptococcus, but these antibodies mistakenly target the body’s own tissues, particularly in the heart, joints, skin, and central nervous system. This autoimmune cross-reactivity underlies the inflammatory lesions characteristic of rheumatic fever, including carditis, arthritis, chorea, erythema marginatum, and subcutaneous nodules.
Hypersensitivity Type in Rheumatic Fever
Rheumatic fever is primarily associated with type II hypersensitivity reactions. In type II hypersensitivity, antibodies bind to antigens on the surface of host cells or extracellular matrix components, leading to cell damage and inflammation. In the context of rheumatic fever, antibodies produced against streptococcal M proteins cross-react with cardiac myosin and other tissue antigens. This antibody-mediated attack triggers complement activation and recruitment of inflammatory cells, resulting in tissue injury, particularly in the heart valves.
Clinical Manifestations Linked to Hypersensitivity
The type II hypersensitivity response in rheumatic fever manifests through a range of clinical features, often appearing two to four weeks after a streptococcal throat infection. Understanding these symptoms is critical for timely diagnosis and management
- CarditisInflammation of the heart can affect the endocardium, myocardium, and pericardium. Valve damage, particularly of the mitral and aortic valves, may occur, leading to long-term complications such as rheumatic heart disease.
- PolyarthritisMigratory arthritis often affects large joints like knees, elbows, and ankles. The inflammatory process is a direct result of immune-mediated tissue damage.
- ChoreaAlso known as Sydenham chorea, this neurological manifestation involves involuntary, rapid movements, thought to arise from autoimmune cross-reactivity in the basal ganglia.
- Skin ManifestationsErythema marginatum presents as a non-pruritic rash with pink rings on the trunk and proximal limbs. Subcutaneous nodules, small, painless lumps over joints, may also occur.
Laboratory and Diagnostic Evidence
Diagnosis of rheumatic fever involves both clinical criteria and laboratory tests. Evidence of recent streptococcal infection, such as elevated antistreptolysin O (ASO) titers or anti-DNase B antibodies, supports the diagnosis. Additionally, markers of inflammation, including elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are typically present. Cardiac evaluation using echocardiography can reveal valvular involvement, helping to confirm the type II hypersensitivity-mediated damage in the heart.
Management and Treatment
Effective management of rheumatic fever focuses on addressing both the streptococcal infection and the immune-mediated inflammation. Antibiotic therapy, such as penicillin, is used to eradicate the streptococcal bacteria and prevent recurrence. Anti-inflammatory agents, including aspirin and corticosteroids, help control the immune response and reduce tissue damage. In severe cases, particularly when carditis leads to significant valve dysfunction, surgical interventions may be necessary.
Long-Term Prevention
Since rheumatic fever can lead to chronic rheumatic heart disease, long-term prophylaxis is often recommended. This includes regular administration of antibiotics, such as monthly intramuscular benzathine penicillin, to prevent recurrent streptococcal infections. Patient education, prompt treatment of sore throats, and monitoring of cardiac function are essential components of long-term care.
Rheumatic fever exemplifies the consequences of type II hypersensitivity, where antibodies intended to combat infection inadvertently target the body’s own tissues. The resulting inflammation can affect multiple organ systems, with cardiac involvement posing the greatest risk for long-term morbidity. Early recognition, prompt treatment of streptococcal infections, and management of autoimmune inflammation are crucial in preventing severe complications. Understanding the hypersensitivity mechanisms underlying rheumatic fever not only clarifies its pathophysiology but also guides effective therapeutic strategies and long-term preventive measures.